| NCT ID | Title | Status | Phases | Start Date | Completion Date | Primary Completion Date |
|---|---|---|---|---|---|---|
| NCT05108623 | A Study Investigating agenT-797 in Participants With Relapsed/Refractory Solid Tumors | COMPLETED | PHASE1 | 2022-01-28 | 2024-01-02 | 2024-01-02 |
| NCT04754100 | agenT-797 in Participants With Relapsed/Refractory Multiple Myeloma | COMPLETED | PHASE1 | 2021-03-29 | 2023-05-31 | 2023-01-13 |
| NCT04582201 | Evaluate the Safety of agenT-797 in Participants With Moderate to Severe Difficulty Breathing Secondary to SARS-CoV-2 | COMPLETED | PHASE1, PHASE2 | 2020-09-21 | 2023-04-23 | 2023-04-23 |